{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:46:31Z","timestamp":1791827191966,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Sichuan Province","award":["2024NSFSC1880"],"award-info":[{"award-number":["2024NSFSC1880"]}]},{"name":"the Natural Science Foundation of Sichuan Province","award":["2024NSFSC0767"],"award-info":[{"award-number":["2024NSFSC0767"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16558-2","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:25:00Z","timestamp":1784265900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A new prognostic perspective on preoperative coagulation parameters for lung adenocarcinoma patients: development and validation of the DFP score"],"prefix":"10.1186","volume":"26","author":[{"given":"Lubei","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"3","key":"16558_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"16558_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejca.2017.01.006","volume":"75","author":"D Walder","year":"2017","unstructured":"Walder D, O\u2019Brien M. Looking back and to the future: Are we improving \u2018cure\u2019 in non-small cell lung cancer? Eur J cancer (Oxford England: 1990). 2017;75:192\u20134.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"issue":"3","key":"16558_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/cas.15254","volume":"113","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li Y, Lyu J, Shi F, Kong Y, Sheng C, Wang S, Wang Q. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. Cancer Sci. 2022;113(3):891\u2013903.","journal-title":"Cancer Sci"},{"issue":"6","key":"16558_CR4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/JLB.5MA0722-757RRR","volume":"112","author":"F Yang","year":"2022","unstructured":"Yang F, Zeng Z, Li Y, Zhang D, Wei F, Zhao H, Zhang P, Ren X. The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancer. J Leukoc Biol. 2022;112(6):1605\u201319.","journal-title":"J Leukoc Biol"},{"issue":"26","key":"16558_CR5","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41388-021-01853-y","volume":"40","author":"J Wu","year":"2021","unstructured":"Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, Xu B. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene. 2021;40(26):4413\u201324.","journal-title":"Oncogene"},{"issue":"16","key":"16558_CR6","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1158\/0008-5472.CAN-22-3140","volume":"83","author":"F Fan","year":"2023","unstructured":"Fan F, Gao J, Zhao Y, Wang J, Meng L, Ma J, Li T, Han H, Lai J, Gao Z, et al. Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2\u2009+\u2009Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma. Cancer Res. 2023;83(16):2690\u2013703.","journal-title":"Cancer Res"},{"issue":"5","key":"16558_CR7","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jcsm.13032","volume":"13","author":"M Song","year":"2022","unstructured":"Song M, Zhang Q, Song C, Liu T, Zhang X, Ruan G, Tang M, Xie H, Zhang H, Ge Y, et al. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. J cachexia sarcopenia muscle. 2022;13(5):2504\u201314.","journal-title":"J cachexia sarcopenia muscle"},{"issue":"1","key":"16558_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12672-023-00851-8","volume":"14","author":"E Topkan","year":"2023","unstructured":"Topkan E, Kucuk A, Ozkan EE, Ozturk D, Besen AA, Mertsoylu H, Pehlivan B, Selek U. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB\/C non-small-cell lung cancer. Discover Oncol. 2023;14(1):230.","journal-title":"Discover Oncol"},{"key":"16558_CR9","doi-asserted-by":"crossref","unstructured":"Jiang Z, Luo Y, Zhang L, Li H, Pan C, Yang H, Cheng T, Chen J. A Novel risk score model of lactate metabolism for predicting over survival and immune signature in lung adenocarcinoma. Cancers. 2022;14(15):3727.","DOI":"10.3390\/cancers14153727"},{"key":"16558_CR10","doi-asserted-by":"publisher","first-page":"1201573","DOI":"10.3389\/fimmu.2023.1201573","volume":"14","author":"Q Ren","year":"2023","unstructured":"Ren Q, Zhang P, Lin H, Feng Y, Chi H, Zhang X, Xia Z, Cai H, Yu Y. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts. Front Immunol. 2023;14:1201573.","journal-title":"Front Immunol"},{"issue":"1","key":"16558_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12672-023-00802-3","volume":"14","author":"Y Lei","year":"2023","unstructured":"Lei Y, Zhou B, Meng X, Liang M, Song W, Liang Y, Gao Y, Wang M. A risk score model based on lipid metabolism-related genes could predict response to immunotherapy and prognosis of lung adenocarcinoma: a multi-dataset study and cytological validation. Discover Oncol. 2023;14(1):188.","journal-title":"Discover Oncol"},{"issue":"1","key":"16558_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40164-023-00388-0","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yang Y, Lin W, Shao F, Gao Y, He J. Complement-related molecular classification and a gene signature for lung adenocarcinoma. Experimental Hematol Oncol. 2023;12(1):22.","journal-title":"Experimental Hematol Oncol"},{"issue":"1","key":"16558_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12859-022-04926-1","volume":"23","author":"X Wen","year":"2022","unstructured":"Wen X, Leng P, Wang J, Yang G, Zu R, Jia X, Zhang K, Mengesha BA, Huang J, Wang D, et al. Clinlabomics: leveraging clinical laboratory data by data mining strategies. BMC Bioinformatics. 2022;23(1):387.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"16558_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ijc.28995","volume":"136","author":"K Zhang","year":"2015","unstructured":"Zhang K, Lai Y, Axelrod R, Campling B, Hyslop T, Civan J, Solomides C, Myers RE, Lu B, Bar Ad V, et al. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests. Int J Cancer. 2015;136(2):382\u201391.","journal-title":"Int J Cancer"},{"issue":"1","key":"16558_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12672-022-00571-5","volume":"13","author":"M Gou","year":"2022","unstructured":"Gou M, Zhang Y. Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy. Discover Oncol. 2022;13(1):118.","journal-title":"Discover Oncol"},{"issue":"1","key":"16558_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12672-023-00760-w","volume":"14","author":"F Tang","year":"2023","unstructured":"Tang F, Chen X, Liu JS, Liu ZY, Yang JZ, Wang ZF, Li ZQ. TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas. Discover Oncol. 2023;14(1):148.","journal-title":"Discover Oncol"},{"issue":"26","key":"16558_CR17","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"16558_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","volume":"3","author":"HF Dvorak","year":"2015","unstructured":"Dvorak HF. Tumors: wounds that do not heal-redux. Cancer Immunol Res. 2015;3(1):1\u201311.","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"16558_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/thx.43.12.978","volume":"43","author":"R Milroy","year":"1988","unstructured":"Milroy R, Douglas JT, Campbell J, Carter R, Lowe GD, Banham SW. Abnormal haemostasis in small cell lung cancer. Thorax. 1988;43(12):978\u201381.","journal-title":"Thorax"},{"issue":"2","key":"16558_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12094-015-1350-7","volume":"18","author":"LR Zhu","year":"2016","unstructured":"Zhu LR, Li J, Chen P, Jiang Q, Tang XP. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Clin Transl Oncol. 2016;18(2):178\u201388.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"16558_CR21","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/cncr.11432","volume":"97","author":"G Buccheri","year":"2003","unstructured":"Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer. 2003;97(12):3044\u201352.","journal-title":"Cancer"},{"key":"16558_CR22","doi-asserted-by":"crossref","unstructured":"Wu LL, Lin WK, Qian JY, Ma SS, Li MJ, Li K, Li ZX, Lan G, Xie D. Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors. Eur J Cardiothorac Surg. 2023;64(5):ezad313.","DOI":"10.1093\/ejcts\/ezad313"},{"issue":"12","key":"16558_CR23","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.21037\/jtd-23-1730","volume":"15","author":"Y Luo","year":"2023","unstructured":"Luo Y, Lin K, Zhang M, Goto T, Brueckl WM, Lin J, Liu X, Weng J, Ye Y. Combination of the platelet-to-lymphocyte ratio and fibrinogen may predict 5-year overall survival of patient in non-small cell lung cancer treated with surgery. J Thorac Dis. 2023;15(12):6967\u201375.","journal-title":"J Thorac Dis"},{"key":"16558_CR24","doi-asserted-by":"publisher","first-page":"1273422","DOI":"10.3389\/fimmu.2023.1273422","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Yin Z, Luan Z, Zhang C, Wang Y, Zhang K, Chen F, Yang Z, Tian Y. Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients. Front Immunol. 2023;14:1273422.","journal-title":"Front Immunol"},{"issue":"6","key":"16558_CR25","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.3934\/mbe.2023470","volume":"20","author":"M Han","year":"2023","unstructured":"Han M, Wang X, Li Y, Tan J, Li C, Sheng W. Identification of coagulation-associated subtypes of lung adenocarcinoma and establishment of prognostic models. Math Biosci Eng. 2023;20(6):10626\u201358.","journal-title":"Math Biosci Eng"},{"issue":"8","key":"16558_CR26","doi-asserted-by":"publisher","first-page":"e2120633","DOI":"10.1001\/jamanetworkopen.2021.20633","volume":"4","author":"V Giannakeas","year":"2021","unstructured":"Giannakeas V, Narod SA. Incidence of Cancer Among Adults With Thrombocytosis in Ontario, Canada. JAMA Netw Open. 2021;4(8):e2120633.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"16558_CR27","doi-asserted-by":"publisher","first-page":"e2141633","DOI":"10.1001\/jamanetworkopen.2021.41633","volume":"5","author":"V Giannakeas","year":"2022","unstructured":"Giannakeas V, Kotsopoulos J, Cheung MC, Rosella L, Brooks JD, Lipscombe L, Akbari MR, Austin PC, Narod SA. Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period. JAMA Netw Open. 2022;5(1):e2141633.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"16558_CR28","doi-asserted-by":"publisher","first-page":"e2331197","DOI":"10.1001\/jamanetworkopen.2023.31197","volume":"6","author":"LNC Boyd","year":"2023","unstructured":"Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, et al. Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers. JAMA Netw Open. 2023;6(8):e2331197.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"16558_CR29","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.7150\/jca.67428","volume":"13","author":"R Zu","year":"2022","unstructured":"Zu R, Wu L, Zhou R, Wen X, Cao B, Liu S, Yang G, Leng P, Li Y, Zhang L, et al. A new classifier constructed with platelet features for malignant and benign pulmonary nodules based on prospective real-world data. J Cancer. 2022;13(8):2515\u201327.","journal-title":"J Cancer"},{"key":"16558_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2020.05.043","volume":"509","author":"R Zu","year":"2020","unstructured":"Zu R, Yu S, Yang G, Ge Y, Wang D, Zhang L, Song X, Deng Y, He Q, Zhang K, et al. Integration of platelet features in blood and platelet rich plasma for detection of lung cancer. Clin Chim Acta. 2020;509:43\u201351.","journal-title":"Clin Chim Acta"},{"key":"16558_CR31","doi-asserted-by":"publisher","first-page":"106777","DOI":"10.1016\/j.phrs.2023.106777","volume":"191","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yu S, Li X, Wen X, Liu S, Zu R, Ren H, Li T, Yang C, Luo H. Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer? Pharmacol Res. 2023;191:106777.","journal-title":"Pharmacol Res"},{"issue":"7","key":"16558_CR32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00262-023-03392-9","volume":"72","author":"M Li","year":"2023","unstructured":"Li M, Zhao S, Lopez G, Secor A, Das P, Surya N, Grogan M, Patel S, Chakravarthy K, Miah A, et al. Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy. Cancer Immunol immunotherapy: CII. 2023;72(7):2067\u201374.","journal-title":"Cancer Immunol immunotherapy: CII"},{"issue":"20","key":"16558_CR33","doi-asserted-by":"publisher","first-page":"20266","DOI":"10.1002\/cam4.6551","volume":"12","author":"Q He","year":"2023","unstructured":"He Q, Luo Z, Zou H, Ye B, Wu L, Deng Y, Yang M, Wang D, Wang Q, Zhang K. A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma. Cancer Med. 2023;12(20):20266\u201376.","journal-title":"Cancer Med"},{"issue":"8","key":"16558_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3109\/09537104.2016.1169265","volume":"27","author":"JS Pyo","year":"2016","unstructured":"Pyo JS, Sohn JH, Kang G. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets. 2016;27(8):722\u20138.","journal-title":"Platelets"},{"key":"16558_CR35","doi-asserted-by":"crossref","unstructured":"Chen J, Zhong Z, Li J, Yu J, Yu Y, Li B, Mao H, Li Z. Effect of mean platelet volume to platelet count ratio on mortality in peritoneal dialysis. Mediators Inflamm. 2022;2022:6922809.","DOI":"10.1155\/2022\/6922809"},{"key":"16558_CR36","doi-asserted-by":"publisher","first-page":"695316","DOI":"10.3389\/fonc.2021.695316","volume":"11","author":"J Wach","year":"2021","unstructured":"Wach J, Apallas S, Schneider M, Weller J, Schuss P, Vatter H, Herrlinger U, G\u00fcresir E. Mean Platelet Volume\/Platelet Count Ratio and Risk of Progression in Glioblastoma. Front Oncol. 2021;11:695316.","journal-title":"Front Oncol"},{"key":"16558_CR37","doi-asserted-by":"publisher","first-page":"103427","DOI":"10.1016\/j.critrevonc.2021.103427","volume":"164","author":"Y Ishibashi","year":"2021","unstructured":"Ishibashi Y, Tsujimoto H, Sugasawa H, Kouzu K, Itazaki Y, Sugihara T, Harada M, Ito N, Kishi Y, Ueno H. Prognostic value of platelet-related measures for overall survival in esophageal squamous cell carcinoma: A systematic review and meta-analysis. Crit Rev Oncol\/Hematol. 2021;164:103427.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"16558_CR38","doi-asserted-by":"publisher","first-page":"902955","DOI":"10.3389\/fonc.2022.902955","volume":"12","author":"A Ma","year":"2022","unstructured":"Ma A, Wang G, Du Y, Guo W, Guo J, Hu Y, Bai D, Huang H, Zhuang L, Chen J, et al. The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer. Front Oncol. 2022;12:902955.","journal-title":"Front Oncol"},{"issue":"1","key":"16558_CR39","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1038\/s41598-017-03772-z","volume":"7","author":"MM Cui","year":"2017","unstructured":"Cui MM, Li N, Liu X, Yun ZY, Niu Y, Zhang Y, Gao B, Liu T, Wang RT. Platelet distribution width correlates with prognosis of non-small cell lung cancer. Sci Rep. 2017;7(1):3456.","journal-title":"Sci Rep"},{"issue":"4","key":"16558_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1164\/rccm.202007-2791OC","volume":"204","author":"MK Gould","year":"2021","unstructured":"Gould MK, Huang BZ, Tammemagi MC, Kinar Y, Shiff R. Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data. Am J Respir Crit Care Med. 2021;204(4):445\u201353.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"16558_CR41","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","volume":"12","author":"C Hinterleitner","year":"2021","unstructured":"Hinterleitner C, Str\u00e4hle J, Malenke E, Hinterleitner M, Henning M, Seehawer M, Bilich T, Heitmann J, Lutz M, Mattern S, et al. Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nat Commun. 2021;12(1):7005.","journal-title":"Nat Commun"},{"issue":"5","key":"16558_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, Lecumberri R, Mandala M, Maraveyas A, Pabinger I, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34(5):452\u201367.","journal-title":"Ann Oncol"},{"issue":"1","key":"16558_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(01)00619-2","volume":"3","author":"GY Lip","year":"2002","unstructured":"Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27\u201334.","journal-title":"Lancet Oncol"},{"issue":"10","key":"16558_CR44","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2018.07.052","volume":"44","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu Z, Qiu Y, Zhang J, Wu H, Liang R, Chen G, Qin G, Li Y, Zou D. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2018;44(10):1494\u2013503.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"16558_CR45","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4065\/82.7.864","volume":"82","author":"AH Kamal","year":"2007","unstructured":"Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007;82(7):864\u201373.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"16558_CR46","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158\u201364.","journal-title":"Haematologica"},{"key":"16558_CR47","doi-asserted-by":"publisher","first-page":"876051","DOI":"10.3389\/fonc.2022.876051","volume":"12","author":"MJ Lee","year":"2022","unstructured":"Lee MJ, Weng CM, Chao W, Fang YF, Chung FT, Lin CH, Kuo HP. Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma. Front Oncol. 2022;12:876051.","journal-title":"Front Oncol"},{"issue":"9","key":"16558_CR48","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1245\/s10434-022-11835-3","volume":"29","author":"M Iwasaki","year":"2022","unstructured":"Iwasaki M, Ishihara S, Okada S, Shimegi R, Shimomura M, Inoue M. Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer. Ann Surg Oncol. 2022;29(9):5699\u2013707.","journal-title":"Ann Surg Oncol"},{"key":"16558_CR49","doi-asserted-by":"publisher","first-page":"8481","DOI":"10.2147\/CMAR.S264856","volume":"12","author":"Z Bian","year":"2020","unstructured":"Bian Z, Meng J, Niu Q, Jin X, Wang J, Feng X, Che H, Zhou J, Zhang L, Zhang M, et al. Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin\/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer. Cancer Manage Res. 2020;12:8481\u201390.","journal-title":"Cancer Manage Res"},{"issue":"2","key":"16558_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-2007-994918","volume":"25","author":"I Gouin-Thibault","year":"1999","unstructured":"Gouin-Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost. 1999;25(2):167\u201372.","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"16558_CR51","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","volume":"121","author":"JW Weisel","year":"2013","unstructured":"Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121(10):1712\u20139.","journal-title":"Blood"},{"key":"16558_CR52","doi-asserted-by":"crossref","unstructured":"Hisada Y, Mackman N. Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer. Cancers (Basel). 2021;13(15):3839.","DOI":"10.3390\/cancers13153839"},{"issue":"4","key":"16558_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0039-1688495","volume":"45","author":"HC Kwaan","year":"2019","unstructured":"Kwaan HC, Lindholm PF. Fibrin and Fibrinolysis in Cancer. Semin Thromb Hemost. 2019;45(4):413\u201322.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"16558_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.0.CO;2-Z","volume":"79","author":"R Koom\u00e4gi","year":"1998","unstructured":"Koom\u00e4gi R, Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer. 1998;79(1):19\u201322.","journal-title":"Int J Cancer"},{"issue":"3\u20134","key":"16558_CR55","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.bjc.6690073","volume":"79","author":"M Sawada","year":"1999","unstructured":"Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K, Yoshizawa Y. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer. 1999;79(3\u20134):472\u20137.","journal-title":"Br J Cancer"},{"issue":"7","key":"16558_CR56","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/JTO.0b013e31817c1b21","volume":"3","author":"S Regina","year":"2008","unstructured":"Regina S, Rollin J, Bl\u00e9chet C, Iochmann S, Reverdiau P, Gruel Y. Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. J Thorac Oncol. 2008;3(7):689\u201397.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"16558_CR57","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1373\/clinchem.2009.123695","volume":"55","author":"S Regina","year":"2009","unstructured":"Regina S, Valentin JB, Lachot S, Lemari\u00e9 E, Rollin J, Gruel Y. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Clin Chem. 2009;55(10):1834\u201342.","journal-title":"Clin Chem"},{"issue":"1","key":"16558_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.20892\/j.issn.2095-3941.2017.0124","volume":"15","author":"W Huang","year":"2018","unstructured":"Huang W, Wang S, Zhang H, Zhang B, Wang C. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer biology Med. 2018;15(1):88\u201396.","journal-title":"Cancer biology Med"},{"issue":"1","key":"16558_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AYY. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022;8(1):11.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"16558_CR60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12890-022-01901-7","volume":"22","author":"J Wang","year":"2022","unstructured":"Wang J, Li H, Xu R, Lu T, Zhao J, Zhang P, Qu L, Zhang S, Guo J, Zhang L. The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery. BMC Pulm Med. 2022;22(1):104.","journal-title":"BMC Pulm Med"},{"key":"16558_CR61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biopha.2016.02.030","volume":"81","author":"Y Chen","year":"2016","unstructured":"Chen Y, Yu H, Wu C, Li J, Jiao S, Hu Y, Tao H, Wu B, Li A. Prognostic value of plasma D-dimer levels in patients with small-cell lung cancer. Biomed pharmacotherapy = Biomedecine pharmacotherapie. 2016;81:210\u20137.","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"16558_CR62","doi-asserted-by":"publisher","first-page":"853941","DOI":"10.3389\/fmed.2022.853941","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Yan S, Zhang X, Xiang M, Zhang C, Gu L, Wei X, You C, Chen S, Zeng D, et al. Circulating D-Dimers Increase the Risk of Mortality and Venous Thromboembolism in Patients With Lung Cancer: A Systematic Analysis Combined With External Validation. Front Med. 2022;9:853941.","journal-title":"Front Med"},{"issue":"5","key":"16558_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","volume":"121","author":"E Campello","year":"2019","unstructured":"Campello E, Ilich A, Simioni P, Key NS. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019;121(5):359\u201371.","journal-title":"Br J Cancer"},{"key":"16558_CR64","doi-asserted-by":"crossref","unstructured":"Guo J, Gao Y, Gong Z, Dong P, Mao Y, Li F, Rong J, Zhang J, Zhou Y, Feng H et al. Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients. Biomed Res Int. 2021;2021:9623571.","DOI":"10.1155\/2021\/9623571"},{"issue":"11","key":"16558_CR65","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00595-020-02019-1","volume":"50","author":"S Ohara","year":"2020","unstructured":"Ohara S, Suda K, Tomizawa K, Takemoto T, Fujino T, Hamada A, Koga T, Nishino M, Chiba M, Sato K, et al. Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer. Surg Today. 2020;50(11):1427\u201333.","journal-title":"Surg Today"},{"issue":"2","key":"16558_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2006.03.015","volume":"53","author":"D Antoniou","year":"2006","unstructured":"Antoniou D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, Papageorgiou C, Dariotaki F, Chaimala D, Veslemes M. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006;53(2):205\u201310.","journal-title":"Lung Cancer"},{"issue":"23","key":"16558_CR67","first-page":"6966","volume":"62","author":"JS Palumbo","year":"2002","unstructured":"Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 2002;62(23):6966\u201372.","journal-title":"Cancer Res"},{"key":"16558_CR68","unstructured":"Raber MN. Coagulation Tests. In: Clinical Methods: The History, Physical, and Laboratory Examinations. edn. Edited by Walker HK, Hall WD, Hurst JW. Boston: Butterworths Copyright \u00a9 1990, Butterworth Publishers, a division of Reed Publishing.; 1990."},{"key":"16558_CR69","unstructured":"Yang R, Zubair M, Moosavi L. Prothrombin Time. StatPearls. edn. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2026. StatPearls Publishing LLC.; 2026."},{"key":"16558_CR70","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.2147\/CMAR.S246695","volume":"12","author":"L Zhang","year":"2020","unstructured":"Zhang L, Ye J, Luo Q, Kuang M, Mao M, Dai S, Wang X. Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT). Cancer Manage Res. 2020;12:5373\u201384.","journal-title":"Cancer Manage Res"},{"issue":"5","key":"16558_CR71","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.trecan.2021.12.008","volume":"8","author":"A Galmiche","year":"2022","unstructured":"Galmiche A, Rak J, Roumenina LT, Saidak Z. Coagulome and the tumor microenvironment: an actionable interplay. Trends Cancer. 2022;8(5):369\u201383.","journal-title":"Trends Cancer"},{"issue":"52","key":"16558_CR72","doi-asserted-by":"publisher","first-page":"43565","DOI":"10.1074\/jbc.M112.401760","volume":"287","author":"D Garnier","year":"2012","unstructured":"Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T, Rak J. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem. 2012;287(52):43565\u201372.","journal-title":"J Biol Chem"},{"issue":"6","key":"16558_CR73","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","volume":"24","author":"N Mackman","year":"2004","unstructured":"Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24(6):1015\u201322.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"16558_CR74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-2004-822969","volume":"30","author":"PM Fernandez","year":"2004","unstructured":"Fernandez PM, Patierno SR, Rickles FR. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost. 2004;30(1):31\u201344.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"16558_CR75","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI117451","volume":"94","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Deng Y, Luther T, M\u00fcller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994;94(3):1320\u20137.","journal-title":"J Clin Invest"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16558-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:01:58Z","timestamp":1791824518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16558-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16558"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16558-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research related to human use has complied with all the relevant national regulations, institutional policies and follows the tenets of the Helsinki Declaration, and has been approved by the Institutional Ethics Committee of The Sichuan Cancer Hospital. The Institutional Review Board (IRB) of the Sichuan Cancer Hospital approved this retrospective study (IRB code: SCCHEC-02-2021-064). This retrospective study has been approved to waive informed consent by the Institutional Review Board of the Sichuan Cancer Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1219"}}